Assertio prices $60 million convertible senior notes offering to refinance existing 13% senior secured notes due 2024

Lake forest, ill., aug. 22, 2022 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a specialty pharmaceutical company offering differentiated products to patients, today announced the pricing of its offering of $60 million aggregate principal amount of 6.50% convertible senior notes due 2027 (the “convertible notes”) in a private offering to qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “securities act”). the issuance and sale of the convertible notes are scheduled to settle on august 25, 2022, subject to customary closing conditions. assertio also granted the initial purchaser of the convertible notes an option to purchase, within a 13-day period beginning on, and including, the date on which the convertible notes are first issued, up to an additional $10 million principal amount of convertible notes.
ASRT Ratings Summary
ASRT Quant Ranking